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Introduction
Zilpaterol-HCl is an orally active b-adrenergic agonist that repartitions nutrient use 
in cattle and has been approved for use during the final 20 to 40 days of the finishing 
period. Zilpaterol administration to finishing cattle increases average daily gain, feed 
efficiency, hot carcass weight, ribeye area, and dressing percentage; however, zilpaterol 
decreases meat tenderness, which is detectable by sensory panelists. Attenuation of 
zilpaterol’s effect on tenderness would improve its benefits to cattle producers.
Decreases in tenderness of meat from cattle fed zilpaterol may be closely related to 
decreases in protein degradation in skeletal muscles. Urinary excretion of N-tau-meth-
ylhistidine (NMH) in cattle reflects skeletal muscle protein degradation in vivo and 
provides a convenient research measure of muscle protein degradation. We analyzed 
NMH excretion by cattle fed zilpaterol to estimate the breakdown rate of skeletal-
muscle protein.
Materials and Methods
Twelve steers of British breeding were used in two sets of six and placed into two 
replicates of similarly designed trials conducted at different times. Steers were blocked 
in each set based on pretrial voluntary feed intake and treatments of zilpaterol were 
randomly assigned within each block. In each replicate, three steers were administered 
zilpaterol (60 mg/day) provided as Zilmax (Intervet Schering-Plough Animal Health, 
Millsboro, DE) throughout the trial, and three steers received no zilpaterol.  Zilpaterol 
treatment was administered in a randomized block design. 
Within each group of six steers, the three steers receiving the same zilpaterol treatment 
were used in concurrent 3 × 3 Latin squares and administered dietary protein treat-
ments. Dietary protein treatments were three corn-based diets: control (10.2% crude 
protein), urea (13.3% crude protein), or dried distillers grains with solubles (DDGS; 
14.9% crude protein). Treatments delivered DDGS (20% of dry matter) and urea (1% 
of dry matter) at inclusion rates similar to those used commonly in corn-based diets fed 
to finishing cattle. DDGS was selected as a supplemental protein source because of its 
relatively high content of undegradable intake protein. Urea was selected as a supple-
mental nitrogen source because it is completely ruminally degraded.  
Steers were housed in metabolism crates to facilitate total collection of urine and feces. 
Steers were fed twice daily in equal amounts. Total urinary excretion of NMH and 
creatinine were analyzed to estimate skeletal-muscle protein degradation. Urinary 
creatinine excretion was used to estimate total skeletal muscle mass.
1 This project was supported by National Research Initiative Competitive Grant no. 2007-35206-17848 
from the USDA Cooperative State Research, Education, and Extension Service.
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Results and Discussion
We measured urinary NMH excretion to estimate in vivo skeletal muscle protein degra-
dation and urinary creatinine excretion as a measure of total skeletal muscle protein 
mass. Thus, the ratio of urinary NMH excretion to urinary creatinine excretion was 
directly related to the proportion of skeletal muscle protein that was degraded.
Total daily excretion of urinary NMH was not affected by zilpaterol (P=0.70; Table 
1). Creatinine excretion was numerically increased by zilpaterol administration. These 
differences together led to an NMH:creatinine ratio that was less (P<0.01) for steers 
receiving zilpaterol than for those not receiving zilpaterol (Figure 1). Zilpaterol reduced 
skeletal-muscle protein degradation in vivo when expressed as a proportion of total 
skeletal-muscle protein mass.
In this trial, steers fed zilpaterol unexpectedly had greater (P<0.01) feed intakes than 
control steers. Generally, skeletal muscle protein turnover (both protein synthesis and 
protein degradation) is increased as feed intake increases; however, zilpaterol reduced 
skeletal muscle protein turnover in spite of greater feed intakes that should have 
increased skeletal muscle protein turnover.  
We observed no effect of dietary protein or its interaction with zilpaterol (P>0.5) on 
urinary excretion of NMH or creatinine or on the ratio between the two. We inter-
preted this to suggest that dietary protein type had no effect on protein degradation or 
that our model was not sensitive enough to detect differences. 
Implications
Zilpaterol administration to cattle receiving corn-based diets reduced skeletal-muscle 
protein degradation. This might explain, in part, reductions in meat tenderness for 
cattle fed zilpaterol.
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Table 1. Effect of zilpaterol-HCl (Zilmax) on N-tau-methylhistidine and creatinine excretion in steers consuming corn-based diets supplemented with no 
protein (control), with dried distillers grains with solubles (DDGS), or with urea
Zilpaterol No zilpaterol P-value
Item Control DDGS Urea Control DDGS Urea SEM Zilpaterol Diet Interaction
Number of steers 4 5 4 6 5 5
N-tau-methylhistidine, mmol/day 1.20 1.20 1.23 1.24 1.26 1.28 0.11 0.71 0.87 0.99
Creatinine, g/day 15.4 15.4 14.8 13.1 13.6 13.8 1.1 0.20 0.89 0.52
N-tau-methylhistidine:creatinine, mmol:g 75.9 77.5 81.4 94.4 92.9 92.5 5.4 <0.01 0.92 0.76
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Figure1. Effect of zilpaterol on the ratio of urinary excretion of N-tau-methylhistidine 
(NMH) to creatinine in steers consuming corn-based diets supplemented with no protein 
(control), with dried distillers grains with solubles (DDGS), or with urea.
